SCOPUS 정보 검색 플랫폼

Clinical Rheumatology

Volumn 31, Issue 1, 2012, Pages 151-155

Re-challenge with Etanercept in patients with Etanercept-induced Neutropenia

(3) Haroon, Muhammad a Daly, Mary a Harney, Sinead a

a University College Cork and INFANT Centre (Ireland)

Author keywords

Etanercept; Neutropenia; Re challenge

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; ETANERCEPT; GOLD; HLA B27 ANTIGEN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANKYLOSING SPONDYLITIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RECHALLENGE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FOOT; HAND; HUMAN; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MONOTHERAPY; NEUTROPENIA; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SACROILIITIS; SYNOVITIS; TREATMENT RESPONSE; WRIST;

ADULT; AGED; ANTIRHEUMATIC AGENTS; DRUG MONITORING; DRUG SUBSTITUTION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEUTROPENIA; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION; TIME FACTORS;

EID: 84856702654 PISSN: 07703198 EISSN: 14349949 Source Type: Journal
DOI: 10.1007/s10067-011-1822-2 Document Type: Review

Times cited : (11)

References (15)

1
- 14044260093
- Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
- DOI 10.1093/rheumatology/keh464
- J Ledingham C Deighton 2005 Update on the British Society of Rheumatology guidelines for prescribing TNFa blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001) Rheumatology 44 157 163 15637039 10.1093/rheumatology/keh464 1:STN:280:DC%2BD2M%2FlsVSksA%3D%3D (Pubitemid 40277395)
- (2005) Rheumatology , vol.44 , Issue.2 , pp. 157-163
- Ledingham, J.¹ Deighton, C.²

2
- 27444444992
- Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
- DOI 10.1136/ard.2005.044941
- DE Furst FC Breedveld JR Kalden GR Burmester JS Smolen JWJ Bijlsma, et al. 2005 Updated consensus on biological agents, specifically tumour necrosis factor a, (TNFa) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases Ann Rheum Dis 64 iv2 iv14 16239380 10.1136/ard.2005.044941 1:CAS:528:DC%2BD2MXht1amtL7L (Pubitemid 41532009)
- (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.SUPPL. 4
- Furst, D.E.¹ Breedveld, F.C.² Kalden, J.R.³ Smolen, J.S.⁴ Burmester, G.R.⁵ Bijlsma, J.W.J.⁶ Dougados, M.⁷ Emery, P.⁸ Keystone, E.C.⁹ Klareskog, L.¹⁰ Mease, P.J.¹¹

3
- 84856736837
- http://www.rheumatology.org.uk/includes/documents/cm-docs/2010/r/ ra-guidelines-on-safety-of-antitnf-therapies-sept-2010.pdf

4
- 34547565474
- Antitumor necrosis factor-induced neutropenia: A case report with double positive rechallenges
- DOI 10.1007/s10067-006-0415-y
- E Montane M Salles A Barriocanal, et al. 2007 Antitumor necrosis factor induced neutropenia: a case report with double positive rechallenges Clin Rheumatol 26 1527 1529 17031483 10.1007/s10067-006-0415-y 1:STN:280: DC%2BD2svjvFWlsg%3D%3D (Pubitemid 47193572)
- (2007) Clinical Rheumatology , vol.26 , Issue.9 , pp. 1527-1529
- Montane, E.¹ Salles, M.² Barriocanal, A.³ Riera, E.⁴ Costa, J.⁵ Tena, X.⁶

5
- 39449135911
- Three significant cases of neutropenia with etanercept [3]
- DOI 10.1093/rheumatology/kem332
- C Wenham K Gadsby C Deighton 2008 Three significant cases of neutropenia with etanercept Rheumatology (Oxford) 47 3 376 377 10.1093/rheumatology/kem332 1:STN:280:DC%2BD1c7hsFyqtA%3D%3D (Pubitemid 351267211)
- (2008) Rheumatology , vol.47 , Issue.3 , pp. 376-377
- Wenham, C.¹ Gadsby, K.² Deighton, C.³

6
- 67349238621
- Adalimumab-induced neutropenia in a patient with rheumatoid arthritis
- 19289296 10.1016/j.jbspin.2008.09.017
- S Ottaviani I Cerf-Payrastre F Kemiche E Pertuiset 2009 Adalimumab-induced neutropenia in a patient with rheumatoid arthritis Joint Bone Spine 76 3 312 313 19289296 10.1016/j.jbspin.2008.09.017
- (2009) Joint Bone Spine , vol.76 , Issue.3 , pp. 312-313
- Ottaviani, S.¹ Cerf-Payrastre, I.² Kemiche, F.³ Pertuiset, E.⁴

7
- 18644384159
- Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy
- EG Favalli M Varenna L Sinigaglia 2005 Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy Clin Exp Rheumatol 23 247 250 15895899 1:STN:280:DC%2BD2M3lsFajsA%3D%3D (Pubitemid 40663009)
- (2005) Clinical and Experimental Rheumatology , vol.23 , Issue.2 , pp. 247-250
- Favalli, E.G.¹ Varenna, M.² Sinigaglia, L.³

8
- 33751270224
- Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis [11]
- DOI 10.1136/ard.2006.056176
- S Rajakulendran K Gadsby D Allen, et al. 2006 Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis Ann Rheum Dis 65 1678 1679 17105865 10.1136/ard.2006.056176 1:STN:280:DC%2BD28nmvVKktg%3D%3D (Pubitemid 44799696)
- (2006) Annals of the Rheumatic Diseases , vol.65 , Issue.12 , pp. 1678-1679
- Rajakulendran, S.¹ Gadsby, K.² Allen, D.³ O'Reilly, S.⁴ Deighton, C.⁵

9
- 19944433874
- Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
- DOI 10.1136/ard.2004.023473
- N Feltelius CM Fored P Blomqvist, et al. 2005 Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept Ann Rheum Dis 64 246 252 15208177 10.1136/ard.2004.023473 1:STN:280: DC%2BD2M%2FitVOruw%3D%3D (Pubitemid 40193621)
- (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.2 , pp. 246-252
- Feltelius, N.¹ Fored, C.M.² Blomqvist, P.³ Bertilsson, L.⁴ Geborek, P.⁵ Jacobsson, L.T.⁶ Lindblad, S.⁷ Lysholm, J.⁸ Rantapaa-Dahlqvist, S.⁹ Saxne, T.¹⁰ Klareskog, L.¹¹

10
- 77953097470
- Neutropenia in patients receiving anti-tumor necrosis factor therapy
- 10.1002/acr.20037
- R Hastings T Ding S Butt K Gadsby W Zhang RJ Moots C Deighton 2010 Neutropenia in patients receiving anti-tumor necrosis factor therapy Arthritis Care Res 62 6 764 769 10.1002/acr.20037
- (2010) Arthritis Care Res , vol.62 , Issue.6 , pp. 764-769
- Hastings, R.¹ Ding, T.² Butt, S.³ Gadsby, K.⁴ Zhang, W.⁵ Moots, R.J.⁶ Deighton, C.⁷

11
- 0026510273
- Rechallenge in clozapine-induced agranulocytosis
- 1349691 10.1016/0140-6736(92)91625-I 1:STN:280:DyaK383lt1Gmug%3D%3D
- AZ Safferman JA Lieberman JM Alvir A Howard 1992 Rechallenge in clozapine-induced agranulocytosis Lancet 339 1296 1297 1349691 10.1016/0140-6736(92)91625-I 1:STN:280:DyaK383lt1Gmug%3D%3D
- (1992) Lancet , vol.339 , pp. 1296-1297
- Safferman, A.Z.¹ Lieberman, J.A.² Alvir, J.M.³ Howard, A.⁴

12
- 0029775615
- Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland
- 8894200 10.1192/bjp.169.4.483 1:STN:280:DyaK2s%2FkvFCksg%3D%3D
- K Atkin F Kendall D Gould H Freeman J Liberman D O'Sullivan 1996 Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland Br J Psychiatry 169 483 488 8894200 10.1192/bjp.169.4.483 1:STN:280:DyaK2s%2FkvFCksg%3D%3D
- (1996) Br J Psychiatry , vol.169 , pp. 483-488
- Atkin, K.¹ Kendall, F.² Gould, D.³ Freeman, H.⁴ Liberman, J.⁵ O'Sullivan, D.⁶

13
- 0028301218
- Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection
- A Sjostedt JW Conlan RJ North 1994 Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection Infect Immun 62 7 2779 2783 8005668 1:STN:280:DyaK2c3nsVaqsw%3D%3D (Pubitemid 24203960)
- (1994) Infection and Immunity , vol.62 , Issue.7 , pp. 2779-2783
- Sjostedt, A.¹ Conlan, J.W.² North, R.J.³

14
- 0036390103
- Clinical symptoms and neutropenia: The balance of neutrophil development, functional activity, and cell death
- TW Kuijpers 2002 Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death Eur J Pediatr 1 S75 S82
- (2002) Eur J Pediatr , vol.1
- Kuijpers, T.W.¹

15
- 77957275541
- Late-onset neutropenia after rituximab treatment: Case series and comprehensive review of the literature
- 10.1097/MD.0b013e3181f2caef
- O Wolach O Bairey M Lahav 2010 Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature Medicine (Baltimore) 89 5 308 318 10.1097/MD.0b013e3181f2caef
- (2010) Medicine (Baltimore) , vol.89 , Issue.5 , pp. 308-318
- Wolach, O.¹ Bairey, O.² Lahav, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.